AI assistant
Sending…
Atea Pharmaceuticals, Inc. — Director's Dealing 2025
Jun 25, 2025
33577_dirs_2025-06-24_fff7e82a-edee-4761-abce-fdcf951250a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2025-06-20
Reporting Person: Berman Howard (N/A)
More from Atea Pharmaceuticals, Inc.
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Earnings Release
2026
Jan 8
Major Shareholding Notification
2025
Dec 5